Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2010
12/09/2010US20100311760 Heterocyclic antiviral compounds
12/09/2010US20100311753 C5aR ANTAGONISTS
12/09/2010US20100311749 4-benzoyl-1-substituted-piperazin-2-one derivatives as p2x7 modulators
12/09/2010US20100311748 Heterocyclic amides useful for the treatment of cancer and psoriasis
12/09/2010US20100311747 Dicycloazaalkane derivates, preparation processes and medical uses thereof
12/09/2010US20100311746 Modulators of muscarinic receptors
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311744 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
12/09/2010US20100311736 Pyridosulfonamide derivatives as p13 kinase inhibitors
12/09/2010US20100311735 Inhibitors of human immunodeficiency virus replication
12/09/2010US20100311731 Fluoroquinolone Carboxylic Acid Molecular Crystals
12/09/2010US20100311730 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100310512 Antiviral compounds
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010CA2764339A1 Azole derivatives as wtn pathway inhibitors
12/09/2010CA2764021A1 Gpr 119 modulators
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010CA2757083A1 Amino pyrimidine anticancer compounds
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258706A2 Functionalized ionic liquids, and methods of use thereof
12/08/2010EP2258703A1 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2010EP2258700A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
12/08/2010EP2258698A2 Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
12/08/2010EP2258697A1 Hydroxyquinoxalinecarboxamide derivative
12/08/2010EP2258690A1 Tricyclic amines as intermediates in the synthesis of fungicidal carboxamide derivatives
12/08/2010EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258366A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
12/08/2010EP2257545A1 Pyrrolidinyl derivatives and uses thereof
12/08/2010EP2257544A2 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
12/08/2010EP2257543A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
12/08/2010EP2257542A1 Gamma secretase modulators for the treatment of alzheimer ' s disease
12/08/2010EP2257541A1 Modulators for amyloid beta
12/08/2010EP2257540A2 Improved process for eprosartan intermediate
12/08/2010EP2257539A1 Substituted 4-hydroxypyrimidine-5-carboxamides
12/08/2010EP2257538A2 Process
12/08/2010EP2257535A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
12/08/2010EP2257534A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257533A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257531A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
12/08/2010EP2257529A2 Pyridines and pyrazines as inhibitors of pi3k
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP2257297A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
12/08/2010EP2257168A1 Fungicide hydroximoyl-tetrazole derivatives
12/08/2010EP2257167A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
12/08/2010EP1858857B1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
12/08/2010EP1626047B1 Process for producing substituted aminoquinazolinone derivative as a pest control agent
12/08/2010CN1897952B Neutrophilia inhibitor
12/08/2010CN1882570B Quinazoline derivatives
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN101910153A Pyrimidines as kinase inhibitors
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/08/2010CN101910150A 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
12/08/2010CN101910149A Pyridazine fungicides
12/08/2010CN101910142A Modulators for amyloid beta
12/08/2010CN101910133A Heterocycle phenyl amide T-type calcium channel antagonists
12/08/2010CN101910131A Carboxamide, sulfonamide and amine compounds for metabolic disorders
12/08/2010CN101910127A (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
12/08/2010CN101910123A Process for the preparation of 6-substituted-1-(2H)-isoquinolinones
12/08/2010CN101906096A 3,4-dihydropyridine-2-ketone heterocyclic compound and application thereof
12/08/2010CN101906069A (S)-2-substituted-(3'-acetyl-2'-pyridone-1'-yl) acetic acid as well as preparation method and application thereof
12/08/2010CN101284827B Antineoplastic compounds containing triazole ring naphthoyl imines and method for preparing same
12/08/2010CN101212971B 4-phenyl-5-0x0-l,4,5,6,7,8-hexahydr0quin0line derivatives as medicaments for the treatment of infertility
12/08/2010CN101139341B Indazolamides with analgesic activity
12/08/2010CN101080402B Hydantoin derivatives useful as metalloproteinase inhibitors
12/07/2010US7846959 Raf modulators and methods of use
12/07/2010US7846946 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
12/07/2010US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
12/07/2010US7846933 such as 1-(4-Fluorophenyl)-5-(pyridin-4-yl)-4-imidazolin-2-one, having excellent p38 MAP kinase inhibitory action, useful for the treatment of osteoarthritis, arthritis, ulcerative colitis, Crohn's disease, psoriasis, dermatitis, asthma, bronchitis, pneumonia, rhinitis, conjunctivitis or keratitis
12/07/2010US7846931 Pyrrolotriazine compounds as kinase inhibitors
12/07/2010US7846928 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/07/2010US7846560 Material for organic electroluminescence device and electroluminescence device employing the same
12/07/2010US7846559 Heterocyclic compound and an organic light emitting device comprising the same
12/07/2010CA2560221C Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
12/07/2010CA2471883C Phenylpyrimidine amines as ige inhibitors
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/07/2010CA2299632C Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
12/02/2010WO2010138790A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010WO2010138578A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010137302A1 Nitrogen-containing heteroaryl derivatives and fungicides for agricultural and horticultural use
12/02/2010WO2010136755A1 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
12/02/2010WO2010136559A1 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
12/02/2010WO2010136475A1 Substituted quinazolines as fungicides
12/02/2010WO2010136145A1 Pyrazinylpyrazoles
12/02/2010WO2010136137A1 Substituted piperidines
12/02/2010WO2010136128A1 Substituted piperidines
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010WO2010106269A3 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
12/02/2010WO2010069502A3 Tetrazole substituted anthranilic acid amides as pesticides
12/02/2010US20100305326 Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage
12/02/2010US20100305317 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305162 Methods for the Synthesis of Pyridoxamine
12/02/2010US20100305153 Aminoisoquinoline thrombin inhibitor with improved bioavailability
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 1080